Phase I study of the anthrapyrazole biantrazole: clinical results and pharmacology
- 1 January 1991
- journal article
- clinical trial
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 28 (1) , 55-58
- https://doi.org/10.1007/bf00684957
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Determination of the anthrapyrazole anticancer drug CI-941 in plasma and urine by solid-phase extraction and high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Pharmacology of adriamycin: The message to the clinicianEuropean Journal of Cancer and Clinical Oncology, 1988
- The effect of the anthrapyrazole antitumour agent CI941 on rat liver microsome and cytochrome P-450 reductase mediated free radical processesBiochemical Pharmacology, 1987
- Mitoxantrone: A New Anticancer Drug with Significant Clinical ActivityAnnals of Internal Medicine, 1986
- DESIGN, BIOCHEMICAL PHARMACOLOGY, ELECTROCHEMISTRY AND TUMOR BIOLOGY OF ANTITUMOR ANTHRAPYRAZOLES1986
- In vitro DNA strand scission and inhibition of nucleic acid synthesis in L1210 leukemia cells by a new class of DNA complexers, the anthra[1,9-cd]pyrazol-6(2H)-ones (anthrapyrazoles)Biochemical Pharmacology, 1985
- ANTHRAPYRAZOLES, A NEW CLASS OF INTERCALATING AGENTS WITH HIGH-LEVEL, BROAD-SPECTRUM ACTIVITY AGAINST MURINE TUMORS1985
- The Anthracycline Antineoplastic DrugsNew England Journal of Medicine, 1981
- Risk Factors for Doxorubicin-lnduced Congestive Heart FailureAnnals of Internal Medicine, 1979
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977